# Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)

> **NCT01971658** · PHASE3 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 358 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Thalidomide®
- **DRUG:** Cyclophosphamide
- **DRUG:** Velcade®
- **DRUG:** Dexaméthasone

## Key facts

- **NCT ID:** NCT01971658
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 358 (ACTUAL)
- **Last updated:** 2015-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01971658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01971658, "Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01971658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*